Perspectives on the Development of Novel Potentially Active Quinolones Against Tuberculosis and Cancer

Author(s): V. Facchinetti, C. R.B. Gomes, M. V.N. de Souza, T. R.A. Vasconcelos

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 12 , Issue 9 , 2012

Become EABM
Become Reviewer


Quinolones and its derivatives comprise an important group of heterocyclic compounds that exhibit a wide range of pharmacological properties such as antibacterial, antitumor, antiviral, anti-ischemic, antiparasitic and anxiolytic. Persistent efforts have been made over the years to develop novel congeners with superior biological activities and minimal potential for undesirable side-effects. The present review aims to highlight some recent discoveries on the development of novel quinolone-based compounds with potential antitubercular and anticancer activity.

Keywords: Biological activity, cancer, drugs, quinolones, tuberculosis, iodoanilines, BCG, Ciprofloxacin, in vitro, 6-nitroquinolones

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 11 June, 2012
Page: [866 - 874]
Pages: 9
DOI: 10.2174/138955712800959099
Price: $65

Article Metrics

PDF: 33